Funding to support development and commercialisation of RNA technologies

Overview

Funding may be used for:

• preclinical and validation studies, including proof-of-concept, safety, efficacy and stability assessments
• development and optimisation of RNA constructs, delivery systems, or manufacturing or formulation processes
• production of prototype or pilot batches and preparation for GMP manufacturing
• application of enabling technologies to improve product performance, manufacturability or cost-efficiency
• activities supporting regulatory readiness, such as pathway planning, certification or approvals
• commercialisation planning, including reimbursement strategy, market testing and feasibility studies
• engagement preparation with potential manufacturing partners
• development and protection of IP, including patent filings or advice
• access to specialist equipment, infrastructure or external expertise essential to project delivery
• salaries and project consumables directly related to the delivery of project outcomes.

Check if you can apply

To be eligible, applicants must:

• have an Australian business number (ABN)
• be registered for goods and services tax (GST)
• be headquartered in NSW
• hold the IP or have the rights to commercialise the technology/innovation in Australia and major international markets.